Advertisement

Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

LeadXPro AG

leadXpro is a drug discovery company focusing on membrane protein targets such as GPCR’s, ion-channels and transporters. We are committed to the application of biophysical and structure-based methods for the discovery and optimization of next generation lead compounds with unmet efficacy and specificity. leadXpro’s technology platform capitalizes on the expert knowledge regarding membrane protein biochemistry and close collaboration with academic facilities of the Paul Scherrer Institute (PSI) for synchrotron (SLS), X-ray Free Electron Laser (SwissFEL) and the University of Basel (C-CINA) for single particle cryo-electron microscopy (cryo-EM). *

 

Period Start 2018-04-18 existent
Products Industry structure-based drug design
  Industry 2 X-ray crystallography
     
Region Region Aargau (Canton)
  Country Switzerland
  City 5234 Villigen
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: LeadXPro AG. (6/3/19). "Press Release: LeadXPro and Astex Enter Strategic Partnership on Membrane Protein Strcuture Research". Cambridge & Villigen.
     
   
Record changed: 2020-08-04

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for LeadXPro AG


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px




» top